Clinical Trials Browser

Myeloproliferative Disorders

NCT05636514 2026-03-18

CELESTIAL-MDS

Phase 1 Recruiting

12 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT04942080 2026-03-06

CALRSUIVI

Phase NA Recruiting

260 enrolled

Myeloid

Myeloproliferative Disorders, Thrombocythemia, Essential, Thrombocytosis, Primary Myelofibrosis

NCT05440838 2026-03-06

BioPredictor

Recruiting

120 enrolled

Myeloid

Myeloproliferative Disorders

NCT06361641 2025-12-08

PHEMOP

Phase NA Recruiting

70 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07061145 2025-08-06

ED2024

Recruiting

350 enrolled

MyeloidOther hematologic neoplasm

Cardiovascular Diseases, Erectile Dysfunction, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06944119 2025-07-28

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Active not recruiting

250 enrolled

LymphoidMyeloidPlasma cell

Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT06793410 2025-06-05

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Phase 2 Recruiting

100 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

Clinical Trials

IFN&SMP

CELESTIAL-MDS

CALRSUIVI

BioPredictor

PHEMOP

ED2024

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation